SEC Form 4 · accession 0001437749-17-005027
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James G. Atkinson
Director
Period of report
Mar 17, 2017
Accepted (ET)
Mar 21, 2017 · 6:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 17, 2017 | P | 187,500 | $4.00 | A | 621,237 | I | By IRA |
| Common StockF2 | Mar 17, 2017 | P | 187,500 | $4.00 | A | 285,599 | I | By Trust |
| Common StockF3 | holding | — | — | — | 3,825 | I | By Custodian for Child | |
| Common Stock | holding | — | — | — | 11,525 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares directly beneficially owned by an individual retirement account created for the benefit of the reporting person (the "IRA"). The reporting person is the beneficiary of the IRA.
- F2Shares directly beneficially owned by Atkinson Family Revocable Trust Dated 08/26/2013 (the "Trust"). The reporting person a trustee and a co-beneficiary of the Trust.
- F3Shares purchased pursuant to a Rule 10b5-1 trading plan adopted by the reporting person as custodian for a minor child.